Patient Education


When your surgeon applies CaverMap, they are taking added diagnostic steps with confidence to reduce the nerve sparing identification risks associated with your prostate procedure's erectile function outcome.  CaverMap aids in surgical examinations and is a precaution against unseen nerve anatomy variability.

CaverMap allows your doctor to better predict erectile function outcomes and to promptly plan further treatment options.

Ask your doctor about CaverMap.

Contact Us for additional info.

 

Prostate Cancer 

Clinical Studies 

Comparative Effectiveness - Experienced surgeons tested CaverMap’s comparative effectiveness in a multi-center randomized Phase 3 clinical trial for radical prostatectomy erectile function recovery.  Surgeon’s who applied CaverMap demonstrated increased patient erectile function recoveries over those who did not.  The CaverMap patients resulted in higher erection frequencies and longer erection durations.

Surgical Quality - The CaverMap methods quantify and predict erectile function recovery after prostate cancer surgery.  Leading doctors suggest that CaverMap provides a better process for erectile function to survive radical prostatectomy hazards than for the operating risks attributed without the technology.

Treatment  Overview

Prostate cancer is most often contained locally within the prostate. The "Gold Standard" treatment for localized prostate cancer is radical prostatectomy.  Removing the entire prostate and any local surrounding cancer, is a surgeon's primary goal. The operation's most common complication risks are erectile dysfunction and incontinence, caused by operative injury to the cavernous nerve bundles around the prostate. These nerves help conduct erectile function. The percentage of patients experiencing erectile dysfunction complications are highly variable among practitioners.  Not every patient has the same nerve position layout or cancer location, which may create nerve-sparing surgical challenges.

Our CaverMap technology helps surgeons improve their diagnostic standards during nerve-sparing radical prostatectomy. It assists the surgeon in locating and mapping the prostate surrounding cavernous nerves, which are difficult to see and may vary in their course. CaverMap provides a precise nerve performance measured analysis. When CaverMap is effectively utilized to investigate, it supports accurate navigation around vital nerve bundles, allowing the surgeon to spare them operative damage.  When a surgeon truly diagnoses where the working nerves are, they are better able to decide how to cut and keep the nerves intact.

Urologists developed nerve-sparing surgical techniques to preserve a man's potency. While this technique increase chances for maintaining function, its effectiveness ranges from 11% to 86%, depending on the surgical skill and patient's age. A surgeon's standards and practice frequency are important to accepted complications rates and outcomes.

After the prostate is removed, the CaverMap Surgical Aid allows surgeons to measure and confirm nerve function for immediate feedback on likely recovery outcomes and additional available therapies.

Indications and Availabilities

Men who have localized prostate cancer and normal erectile function may benefit from radical prostatectomy surgery with the CaverMap Surgical Aid. Prostate cancer patients should speak with their urologist to determine if the CaverMap Surgical Aid could be of benefit to them.  CaverMap is now commercially available nationwide at many leading prostate cancer treatment centers.

For more information, ask your doctor about CaverMap. For current hospital listing please call us directly at 508-231-1080, or Contact Us

The Facts 

Prostate cancer is the most common internal malignancy among American men, according to the American Cancer Society.   Erectile dysfunction complications risks are varied.

Prostate cancer incidence rates have increased 50 percent from 1989 to 1993, and by the end of 1999 approximately 200,000 new prostate cancer cases will be diagnosed. This increase is due to greater disease awareness and early detection.

Additional Information

Online Patient Education Presentation

For further information regarding prostate cancer, please see our Links Page and consult with your doctor.

 

Supporting references are on file.

Caution: Federal (USA) law prohibits sale unless made by or on the order of a physician trained in prostate surgery.

This device is designed as an adjunct to current prostatectomy procedures in which nerve sparing technique is used. It is not designed to replace the surgeon's expertise in mapping out neurovascular bundles.

This information is for general information purposes only. We recommend you consult with your physician. This is not a substitute for medical care, nor a means of rendering medical advice.

CaverMap is Blue Torch trademark. © Blue Torch 2009. All rights reserved.

Back to Top

 

 

GOLD UROLOGY Journal
Surgical Techniques
Initiatives
Cancer Research
Discovery Health
Urology Channel
OncoLink
Mediconsult
Prostate Cancer Educational Council
Us Too!
cancerfacts.com
Virgil's Online Guide to Fighting Prostate Cancer

Intended Use
The Blue Torch Medical Technologies CaverMap Surgical Aid is intended to provide stimulation to the body to locate and identify nerves and to test their excitability. The device is designed as an adjunct to the current open or laparoscopic prostatectomy and open colorectal procedures in which a nerve sparing technique is used. The Surgical Aid is not designed to replace the surgeon’s expertise in mapping out the neurovascular bundles.

CaverMap must be administered under a doctor's prescription to provide medical benefit.  CaverMap is often not eligible for a patient's insurance company reimbursement. An ABN Form is required to receive patient payments.